Long QT Syndrome Type 1 in an Australian Indigenous Patient

Circ Genom Precis Med. 2020 Apr;13(2):e002813. doi: 10.1161/CIRCGEN.119.002813. Epub 2020 Jan 31.

Anand N Ganesan^{1

2

3}, Carlos G Vanoye⁴, Ferdous Alam⁵, Kathryn E Waddell-Smith^{1

3}, Andrew D McGavigan^{1

3}, Gemma Correnti⁶, Eric Haan^{6

7}, Alex Brown^{2

7}, Jamie Vandenberg⁸, Alfred L George Jr⁴

¹ College of Medicine and Public Health, Flinders University, Adelaide, Australia (A.N.G., K.E.W.-S., A.D.M.).
² South Australian Health and Medical Research Institute, Adelaide, Australia (A.N.G., A.B.).
³ Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, Australia (A.N.G., K.E.W.-S., A.D.M.).
⁴ Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL (C.G.V., A.L.G.).
⁵ Whyalla Hospital and Health Services (F.A.).
⁶ Adult Genetics Unit, Royal Adelaide Hospital, Australia (G.C., E.H.).
⁷ Faculty of Health and Medical Sciences, University of Adelaide, South Australia (E.H., A.B.).
⁸ Victor Chang Cardiac Research Institute, Sydney, Australia (J.V.).

No abstract available

Keywords: Australia; genetics; humans; long QT syndrome; potassium channels.

Publication types